As a tumor inhibitor, p53 plays a pivotal role in cervical cancer 48, He et al. indicate that both RRM1 and RRM2 were positively controlled by mTOR signaling while suppressed by p53 signaling 49. Here, RRM2 is linked to cervical carcinoma.